

 
With 20–30 milligrams, [[euphoria]], [[empathy]], and [[psychedelic experience|psychedelic]] effects become apparent and can last as long as 12 hours.<ref>{{Cite journal | last1 = Wilcox | first1 = J. | title = Psychoactive Properties of Alpha-Methyltryptamine: Analysis from Self Reports of Users | doi = 10.1080/02791072.2012.704592 | journal = Journal of Psychoactive Drugs | volume = 44 | issue = 3 | pages = 274–276 | year = 2012 | pmid =  23061328| pmc = }}</ref> A dose exceeding 40&nbsp;mg is generally considered as strong. In rare cases or extreme doses the duration of effects might exceed 24 hours. αMT in [[freebase (chemistry)|freebase]] [[drug form|form]] is reported by users to have been [[Smoking|smoked]], with doses of between and 2–5 milligrams being cited.<ref name="urlErowid AMT Vault : FAQ by Dialtonez"/><ref name="urlErowid Online Books : TIHKAL - #48 a-MT"/>

 


 
Reported [[side effect]]s include [[anxiety]], restlessness, [[muscle tension]], [[trisma|jaw tightness]], [[pupil dilation]], [[tachycardia]], [[headache]]s, [[nausea]], and [[vomiting]], among other effects that might commonly be attributed to [[LSD]], [[psilocybin]], [[Dimethyltryptamine|DMT]] and [[MDMA]], such as open-eye visuals, closed eye visuals and an altered state of mind.<ref name="urlErowid Online Books : TIHKAL - #48 a-MT"/><ref name="urlErowid AMT Vault : Effects">{{cite web | url = http://www.erowid.org/chemicals/amt/amt_effects.shtml | title = Erowid AMT Vault : Effects | work = | accessdate = }}</ref>

 


 
In spite of some reported experiential similarities to MDMA, the chemicals are structurally unrelated; αMT is a tryptamine while MDMA is a [[phenethylamine]].

 


 
Like many other [[serotonin releasing agent]]s, αMT's analogue [[Alpha-Ethyltryptamine|αET]] has been shown to produce long-lasting serotonergic neurotoxicity at very high doses.<ref name="pmid1722753">{{cite journal |vauthors=Huang XM, Johnson MP, Nichols DE | title = Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) | journal = European Journal of Pharmacology | volume = 200 | issue = 1 | pages = 187–90 |date=July 1991 | pmid = 1722753 | doi = 10.1016/0014-2999(91)90686-K| url = }}</ref> It is possible that αMT could cause the same neurotoxicity.

 

